FOR IMMEDIATE USE
World-first research: the most cost-effective way of
managing the twin epidemics of type 2 diabetes and obesity
On Wednesday, February 25, 2009 leading Australian researchers will reveal the most cost-effective way of managing recently diagnosed type 2 diabetes in the obese over their lifetime.
The startling findings are the result of rigorous research conducted by Monash and Deakin Universities, Melbourne.
Diabetes affects around 1.7 million Australians, of whom 85 – 90 per cent have type 2 diabetes.1 Half of those diagnosed with type 2 diabetes are obese.2 Type 2 diabetes costs the Australian community around $10.3 billion each year.1
To find out more about this world-first research, speak to the following people:
- Professor Paul O’Brien Head of the Centre for Obesity Research and Education (CORE), Monash University, Melbourne
- Assoc Professor John Dixon Formerly from the Centre for Obesity Research and Education (CORE), now a Senior Clinical Scientist at the Baker IDI Heart & Diabetes Institute, Melbourne
- Ms Catherine Keating Study Investigator and Research Fellow, Health Economics Unit, Deakin University, Melbourne
Available for interview upon request.
Full media kit available for download on Wednesday, February 25 from www.vivacommunications.com.au/diabcost
Kirsten Bruce or Sarah Mathiesen from VIVA! Communications on 02 9884 9011 or m. 0401 717 566 / 0400 712 861.
- Diabetes Australia. Diabetes Action, Diabetes Data. Diabetes Australia Canberra 2008.
- Dixon JB, O’Brien PE, Playfair J, Chapman L, Schacter LM, Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastric banding and non-surgical therapy for type 2 diabetes – a randomised trial. JAMA 2008. 299(3): 316-323.